DexCom ROE 2010-2024 | DXCM

Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
DexCom ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.68B $1.98B 31.21%
2024-06-30 $0.67B $2.43B 29.59%
2024-03-31 $0.64B $2.25B 29.43%
2023-12-31 $0.54B $2.07B 25.01%
2023-09-30 $0.38B $2.27B 17.31%
2023-06-30 $0.36B $2.10B 17.27%
2023-03-31 $0.29B $2.23B 13.88%
2022-12-31 $0.34B $2.13B 16.23%
2022-09-30 $0.24B $1.83B 11.74%
2022-06-30 $0.23B $2.26B 10.67%
2022-03-31 $0.26B $2.19B 12.29%
2021-12-31 $0.22B $2.04B 10.74%
2021-09-30 $0.63B $2.14B 32.20%
2021-06-30 $0.62B $2.00B 34.21%
2021-03-31 $0.59B $1.90B 35.61%
2020-12-31 $0.55B $1.83B 39.11%
2020-09-30 $0.23B $1.50B 19.78%
2020-06-30 $0.21B $1.35B 20.83%
2020-03-31 $0.15B $0.94B 18.10%
2019-12-31 $0.10B $0.88B 13.45%
2019-09-30 $-0.17B $0.76B -24.71%
2019-06-30 $-0.17B $0.69B -26.49%
2019-03-31 $-0.13B $0.67B -21.89%
2018-12-31 $-0.13B $0.66B -23.86%
2018-09-30 $0.04B $0.56B 9.34%
2018-06-30 $-0.01B $0.48B -1.17%
2018-03-31 $-0.03B $0.42B -8.11%
2017-12-31 $-0.05B $0.42B -13.94%
2017-09-30 $-0.05B $0.38B -14.77%
2017-06-30 $-0.07B $0.35B -22.07%
2017-03-31 $-0.09B $0.28B -32.90%
2016-12-31 $-0.07B $0.28B -25.42%
2016-09-30 $-0.06B $0.26B -23.33%
2016-06-30 $-0.08B $0.25B -35.91%
2016-03-31 $-0.06B $0.23B -31.37%
2015-12-31 $-0.06B $0.22B -31.61%
2015-09-30 $-0.06B $0.19B -36.14%
2015-06-30 $-0.02B $0.17B -14.61%
2015-03-31 $-0.02B $0.15B -18.25%
2014-12-31 $-0.02B $0.14B -20.67%
2014-09-30 $-0.03B $0.12B -27.76%
2014-06-30 $-0.03B $0.10B -32.09%
2014-03-31 $-0.03B $0.09B -39.88%
2013-12-31 $-0.03B $0.08B -39.34%
2013-09-30 $-0.04B $0.08B -46.98%
2013-06-30 $-0.05B $0.07B -60.73%
2013-03-31 $-0.05B $0.07B -63.35%
2012-12-31 $-0.05B $0.08B -62.07%
2012-09-30 $-0.06B $0.08B -61.70%
2012-06-30 $-0.05B $0.09B -52.81%
2012-03-31 $-0.05B $0.10B -41.82%
2011-12-31 $-0.04B $0.11B -44.78%
2011-09-30 $-0.04B $0.11B -48.14%
2011-06-30 $-0.04B $0.12B -61.99%
2011-03-31 $-0.05B $0.05B -98.95%
2010-12-31 $-0.06B $0.06B -119.57%
2010-09-30 $-0.06B $0.04B -217.14%
2010-06-30 $-0.06B $0.04B -380.33%
2010-03-31 $-0.06B $0.05B -1109.09%
2009-12-31 $-0.05B $-0.02B 2160.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $27.225B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
Edwards Lifesciences (EW) United States $40.042B 24.90
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Masimo (MASI) United States $7.841B 41.99
Glaukos (GKOS) United States $7.219B 0.00
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.684B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00